chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Angiogram pulmonary abnormal, Anion gap, Arteriosclerosis
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Arteriosclerosis coronary artery, Aspartate aminotransferase increased, Bacterial test positive, Blood albumin decreased, Blood alkaline phosphatase normal
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Blood bilirubin normal, Blood calcium decreased, Blood chloride decreased, Blood creatinine normal, Blood glucose normal
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Blood potassium normal, Blood sodium decreased, Blood urea normal, Blood urine absent, Bronchial secretion retention
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Bronchial wall thickening, COVID-19, COVID-19 pneumonia, Chromaturia, Chronic obstructive pulmonary disease
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Condition aggravated, Dyspnoea, Dyspnoea exertional
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Emphysema, Glomerular filtration rate normal, Glucose urine absent, Haematocrit decreased, Haemoglobin normal
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Hyponatraemia, Laboratory test, Lung consolidation, Lung opacity, Lymph node calcification
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Mean cell volume normal, Neutrophil count increased, Nitrite urine absent, Osteopenia, Peripheral arterial occlusive disease
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Platelet count normal, Pleural effusion, Pneumonia, Productive cough, Protein total decreased
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Pulmonary embolism, Pulmonary fibrosis, Pulmonary mass, Pyrexia, Red blood cell count decreased
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Red blood cells urine positive, Respiratory symptom, Right atrial enlargement, Right ventricular enlargement, SARS-CoV-2 test positive
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Scan with contrast abnormal, Type IIa hyperlipidaemia, Urine ketone body present, Urine leukocyte esterase positive, Urobilinogen urine increased
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: White blood cell count increased, White blood cells urine positive, pH urine normal
Clinical narrative: COVID+ 11/6/22.  Vaccination status - moderna x3 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 11/6/2022 Discharge Date: 11/11/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Acute respiratory failure with hypoxia  11/07/2022 Yes ? Pneumonia due to infectious organism 11/07/2022 Yes ? Pneumonia due to COVID-19 virus 11/07/2022 Yes ? Chronic obstructive pulmonary disease with (acute) exacerbation  11/07/2022 Yes ? Peripheral arterial disease  11/07/2022 Yes ? Hyponatremia 11/07/2022 Yes ? Pure hypercholesterolemia 09/29/2022 Yes ? Coronary artery disease involving native coronary artery 04/04/2018 Yes ? Essential hypertension 04/04/2018 Yes ? OSA (obstructive sleep apnea)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:    Patient is a 74 y.o. male who presents to hospital because he had upper respiratory infection symptoms about 2 weeks ago.  He says transiently his symptoms improved but then lately he has noticed worsening shortness of breath and a productive cough.  He believes he has had a fever, but has not checked his temperature at home.  He has underlying chronic obstructive pulmonary disease and uses Trelegy and albuterol at home.  He was brought in by EMS and at that point was found to have O2 saturation on room air of 85%.  He does not use home oxygen.     In the ER, given 125 mg of Solu-Medrol and found to be COVID positive.  The timing is difficult to ascertain considering his infection 2 weeks ago.  Due to his high risk of progression, he will be treated aggressively with steroids and remdesivir. CT thorax revealed no PE, severe emphysematous changes, trace left pleural effusion, and suspicious for pneumonia.    During hospital course patient received five days of steroids and remdesivir. He received five days of azithromycin and rocephin. He is discharged with two additional days of keflex and azithromycin for a 7 day course to treat community acquired pneumonia. Per PT/OT recommends at discharge 4WW and home health. RT50 recommends 2L with activity and no supplementation at rest. Patient is discharged with home oxygen. PCP follow up on 11/16/2022   Patient was seen and examined today. He is requiring 1L NC at rest during exam with SPO2 92%. He reports shortness of breath with activity is improving. Denies fevers, chills, chest pain, abdominal pain, n/v/c/d. He is tolerating oral intake. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired 10/31/22 and was given 11/01/2022, the patient has not had any complications post vaccine.
Age: 49.0
Sex: F
Vaccine: FLUC4
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain
Clinical narrative: Patient experienced immediate pain with injection.  Patient reports that she thinks it was injected into joint space.  Patient has had constant pain, limited range of motion ever since vaccination.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram cerebral normal, Blood sodium decreased, Blood test abnormal, Chest X-ray normal, Computerised tomogram normal
Clinical narrative: On 10/02/2022, I woke up with a headache and fatigue. On 10/03/2022, the headache and fatigue continued but I also developed a low-grade fever and nausea. Those symptoms persisted until 10/12/2022 with almost no change over that period of time. The symptoms were severe enough that I was pretty much consigned to bed. I was able to drink but was not able to eat much at all. I was seen at my health clinic to rule out COVID-19, flu, and I also had a chest x-ray to rule out pneumonia. On 10/06/2022, due to my symptoms, my doctor arranged for me to be seen at the local emergency room where they performed a CT scan, urinalysis, a head MRA, a lumbar puncture and blood work, as well as an additional COVID-19 test. All of those came back negative except for the urinalysis which showed a urinary tract infection. Also, the blood work was abnormal in a number of ways, one of which being low sodium along with elevated factors for inflammation. They started me on a course of antibiotics for the urinary tract infection. I continued with the same symptoms and continued to have repeat blood work done which continued to be abnormal in some respects. On 10/11/2022, my physician started me on a course of 60 milligrams of prednisone once a day. On the morning of 10/12/2022, my symptoms were improved. That same day, I went to the vascular lab and had a Temporal Artery Ultrasound which was also negative. My symptoms began to improve but I continued to have blood work and urinalysis done and they were improving. On 11/03/2022, all of my lab results were completely normal, and I no longer have symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eating disorder, Fatigue, Headache, Inflammatory marker increased, Influenza virus test negative
Clinical narrative: On 10/02/2022, I woke up with a headache and fatigue. On 10/03/2022, the headache and fatigue continued but I also developed a low-grade fever and nausea. Those symptoms persisted until 10/12/2022 with almost no change over that period of time. The symptoms were severe enough that I was pretty much consigned to bed. I was able to drink but was not able to eat much at all. I was seen at my health clinic to rule out COVID-19, flu, and I also had a chest x-ray to rule out pneumonia. On 10/06/2022, due to my symptoms, my doctor arranged for me to be seen at the local emergency room where they performed a CT scan, urinalysis, a head MRA, a lumbar puncture and blood work, as well as an additional COVID-19 test. All of those came back negative except for the urinalysis which showed a urinary tract infection. Also, the blood work was abnormal in a number of ways, one of which being low sodium along with elevated factors for inflammation. They started me on a course of antibiotics for the urinary tract infection. I continued with the same symptoms and continued to have repeat blood work done which continued to be abnormal in some respects. On 10/11/2022, my physician started me on a course of 60 milligrams of prednisone once a day. On the morning of 10/12/2022, my symptoms were improved. That same day, I went to the vascular lab and had a Temporal Artery Ultrasound which was also negative. My symptoms began to improve but I continued to have blood work and urinalysis done and they were improving. On 11/03/2022, all of my lab results were completely normal, and I no longer have symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lumbar puncture normal, Mobility decreased, Nausea, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: On 10/02/2022, I woke up with a headache and fatigue. On 10/03/2022, the headache and fatigue continued but I also developed a low-grade fever and nausea. Those symptoms persisted until 10/12/2022 with almost no change over that period of time. The symptoms were severe enough that I was pretty much consigned to bed. I was able to drink but was not able to eat much at all. I was seen at my health clinic to rule out COVID-19, flu, and I also had a chest x-ray to rule out pneumonia. On 10/06/2022, due to my symptoms, my doctor arranged for me to be seen at the local emergency room where they performed a CT scan, urinalysis, a head MRA, a lumbar puncture and blood work, as well as an additional COVID-19 test. All of those came back negative except for the urinalysis which showed a urinary tract infection. Also, the blood work was abnormal in a number of ways, one of which being low sodium along with elevated factors for inflammation. They started me on a course of antibiotics for the urinary tract infection. I continued with the same symptoms and continued to have repeat blood work done which continued to be abnormal in some respects. On 10/11/2022, my physician started me on a course of 60 milligrams of prednisone once a day. On the morning of 10/12/2022, my symptoms were improved. That same day, I went to the vascular lab and had a Temporal Artery Ultrasound which was also negative. My symptoms began to improve but I continued to have blood work and urinalysis done and they were improving. On 11/03/2022, all of my lab results were completely normal, and I no longer have symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ultrasound Doppler normal, Urinary tract infection, Urine analysis abnormal
Clinical narrative: On 10/02/2022, I woke up with a headache and fatigue. On 10/03/2022, the headache and fatigue continued but I also developed a low-grade fever and nausea. Those symptoms persisted until 10/12/2022 with almost no change over that period of time. The symptoms were severe enough that I was pretty much consigned to bed. I was able to drink but was not able to eat much at all. I was seen at my health clinic to rule out COVID-19, flu, and I also had a chest x-ray to rule out pneumonia. On 10/06/2022, due to my symptoms, my doctor arranged for me to be seen at the local emergency room where they performed a CT scan, urinalysis, a head MRA, a lumbar puncture and blood work, as well as an additional COVID-19 test. All of those came back negative except for the urinalysis which showed a urinary tract infection. Also, the blood work was abnormal in a number of ways, one of which being low sodium along with elevated factors for inflammation. They started me on a course of antibiotics for the urinary tract infection. I continued with the same symptoms and continued to have repeat blood work done which continued to be abnormal in some respects. On 10/11/2022, my physician started me on a course of 60 milligrams of prednisone once a day. On the morning of 10/12/2022, my symptoms were improved. That same day, I went to the vascular lab and had a Temporal Artery Ultrasound which was also negative. My symptoms began to improve but I continued to have blood work and urinalysis done and they were improving. On 11/03/2022, all of my lab results were completely normal, and I no longer have symptoms.
Age: 55.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Headache, Rash
Clinical narrative: RASH ON TORSO , HEADACHE
Age: 67.0
Sex: F
Vaccine: FLUA4
Symptoms: Injected limb mobility decreased, Pain in extremity, Product administered at inappropriate site, X-ray limb
Clinical narrative: The injection was given too high, likely into the joint capsule. Two hours after the injection my arm was terribly sore and had limited ROM. Did not improve with NSAIDS . Visited MD on November7, 2022 with symptoms of pain and limited ROM in left arm. Xrays were done and Medrol dose pack was prescribed. Symptoms improved during the 5 days of the medication but returned once the dose was completed.
Age: 31.0
Sex: F
Vaccine: ANTH, FLU4, TYP, YF
Symptoms: Blood glucose, Confusional state, Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Pt was given anthrax, typhoid, flu and yellow fever on 11/14/2022. Approx. 2 minutes after shots were given pt was noted to be leaning over to her side in the waiting chair, with fist clenched. Pt was not not responsive to verbal or painful stimuli. Pt eyes were dilated, skin were diaphoretic and flushed. Pt was able to answer questions approx. 1 minute after contact. At this time she was A/oX4. Pt then complained of confusion, lightheadedness, and nausea. An ice pack was placed in the back of the pt head and she was placed supine with knees propped up. Ambulance response team was notified and care was transferred with out issues